Masimo Corporation (MASI)

Currency in USD
179.95
+0.01(+0.01%)
Real-time Data·
Showing Masimo historical data. For real-time data please try another search
Day's Range
179.95179.99
52 wk Range
125.94179.99
Key Statistics
Prev. Close
179.95
Open
179.95
Day's Range
179.95-179.99
52 wk Range
125.94-179.99
Volume
3.16M
Average Volume (3m)
1.11M
1-Year Change
7.748%
Book Value / Share
15.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Masimo Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

0 Buy
8 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 180.00
(+0.03% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Masimo Corporation Earnings Call Summary for Q3/2025

  • Masimo's Q3 2025 adjusted EPS of $1.32 exceeded forecasts by 10%, with revenue reaching $371.5 million, driving a 2.75% stock increase to $144.96.
  • Revenue grew 8% year-over-year with a 38% increase in adjusted EPS, while the company maintained strong margins with operating margin rising to 27.1%.
  • Strategic initiatives include an expanded Philips partnership, AI-enabled innovations, and completion of Sound United asset sale, strengthening Masimo's healthcare technology position.
  • The company returned $350 million to shareholders through stock repurchases and provided FY guidance of $1,510-$1,530 million in revenue with EPS of $5.40-$5.55.
  • CEO Katie Szyman expressed confidence in meeting 2025 goals, with further details expected at the December 3rd Investor Day.
Last Updated: 05/11/2025, 09:36 am
Read Full Transcript

Earnings

Latest Release
12/05/2026
EPS / Forecast
1.48 / 1.43
Revenue / Forecast
401M / 398.65M
EPS Revisions
Last 90 days

MASI Income Statement

Compare MASI to Peers and Sector

Metrics to compare
MASI
Peers
Sector
Relationship
P/E Ratio
0.0x0.0x0.0x
PEG Ratio
0.000.000.00
Price/Book
0.0x0.0x0.0x
Price / LTM Sales
0.0x0.0x0.0x
Upside (Analyst Target)
0.0%0.0%0.0%
Fair Value Upside
Unlock0.0%0.0%Unlock

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California. As of June 10, 2026, Masimo Corporation operates as a subsidiary of Danaher Corporation.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
19.17M36.60%3.45B
Other Institutional Investors
35.07M63.40%6.31B
Public Companies & Retail Investors
0.000.00%0.00
Total
54.24M100.00%9.76B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.87%4,644,485835,775
Politan Capital Management, L.P.8.76%4,589,648825,907

People Also Watch

291.45
ALNY
+0.08%
144.06
WING
-1.05%
160.94
NVT
+2.64%
119.96
FORM
+3.58%
198.56
FIVE
+1.38%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.